Time Commitment: 3 Hrs 30 min over 50 days
Credits Available: 3.50 AMA PRA Category 1 Credits™ and ANCC contact hours

Acute myeloid leukemia (AML) continues to be the most common acute leukemia in adults, with an incidence of 5.5 cases per 100,000 persons annually. As such, more education is needed on key topics including use of induction therapy in the non-elderly population, treating suboptimal response to induction therapy, best practices for measurable (or minimal) residual disease assessment, and proper use of maintenance therapy..The goal of this educational curriculum, Turning Complexity into Clarity in AML, is to establish impactful small group interactions between members of the AML care team that will, through a variety of collaborative educational experiences, help them in learning and sharing best practices that will improve outcomes for patients with AML.


CME/CE Accreditation Information

Self Study Modules

Live Group Discussions

  • Meet & Greet

    Please join me for a brief kick off where you'll have a chance to greet other group members and discuss our collective goals and priorities for the next few weeks. I’m really looking forward to seeing you.

  • Live Group Discussion #1: Key Insights on AML

    This virtual live discussion provides an opportunity for the group to convene with their group leader to discuss aspects of the self-study learning modules.

  • Live Group Discussion #2: AML Take-Home Messages: Putting the Evidence to Practice

    This virtual live discussion provides an opportunity for the group to convene with their group leader to discuss aspects of the case-based group tasks.

Group Case Study

  • AML Group Task: Jane's Case

    This group task activity has been designed for the learner to explore a patient case study and to apply the knowledge they have learned throughout the activity to determine the most appropriate way to treat the patient.

  • AML Group Task: Roger's Case

    This group task activity has been designed for the learner to explore a patient case study and to apply the knowledge they have learned throughout the activity to determine the most appropriate way to treat the patient.

Curriculum is Currently Closed

Thank you for your interest. Currently, the curriculum is closed for enrollment but we encourage you to keep an eye out for future opportunities or alternative programs that might align with your educational goals.

View Other Offerings

Completed Groups

Harry Erba, MD, PhD
Professor of Medicine, Director of the Leukemia Program
Completed
David Sallman, MD
MD
Completed
Catherine Lai, MD, MPH
Associate Professor/Physician Leader, Leukemia Clinical Research Unit
Completed
Douglas Tremblay, MD
Assistant Professor
Completed
Richard Stone, MD
Chief of Staff
Completed
Joshua Zeidner, MD
Associate Professor of Medicine
Completed
Amandeep Salhotra, md
Associate Professor
Completed
David Sallman, MD
MD
Completed
Eric Winer, MD
Assistant Professor, Clinical Director
Completed
Nicholas Short, MD
Assistant Professor
Completed